Following a roughly 40% decline in early March, CF PharmTech (02652.HK) closed up 21.39% at HK$27.92 on March 16, 2026, spurred by positive catalysts. On March 13, the IND application for its inhalation dry powder ICF001 (for PAH and PH-ILD) was accepted by the NMPA, potentially filling a domestic void in PH-ILD treatment. While the company has 6 marketed products, its core product CF017 (Budesonide Inhalation) accounts for over 90% of revenue, leaving its risk-resistance structure fragile. The current TTM P/E of 384.57x reflects high market expectations for the innovation pipeline but also carries the risk of a valuation pullback.
NewTimeSpace News,On 16 March, Hatten Land, a Singapore-listed company under judicial management, issued an announcement disclosing that it has used a portion of the loan under the facility agreement signed with Skyone to refinance its indebtedness under the previously entered secured facility agreement with Brilliant. Brilliant has executed a deed of discharge and release, formally terminating the relevant secured facility agreement and the assignment of receivables agreement.
NewTimeSpace News,According to a Singapore Exchange announcement on March 13, Alpha Integrated REIT announced the successful completion of the refinancing of a S$75 million loan maturing in March 2026.
NewTimeSpace News,According to a Singapore Exchange announcement on March 16, Serial Achieva has signed a Memorandum of Understanding (MOU) with UFCT Technology. The two parties intend to explore a long-term strategic cooperation framework focusing on artificial intelligence, cloud computing and other sectors, and plan to explore the possibility of UFCT increasing its shareholding in Serial Achieva within the next two to three years.
NewTimeSpace News,On March 12, Singapore-based investment group Trendlines announced that its portfolio company IBI Ag has successfully completed the Proof of Concept (POC) for its AI-powered de novo protein design platform for novel bioinsecticides.
NewTimeSpace News,On March 13, Singapore-based Addvalue Technologies issued an announcement stating that it has set up a special working group and engaged external professional consulting services to unlock the market value and full potential of its Inter-Satellite Data Relay System (IDRS) business.
As the 2025 "Oversubscription King" under the HKEX Chapter 18C rule, Deepexi Technology (01384.HK) has recently experienced severe share price volatility. As of March 12, 2026, it closed at HK$69.80, with a single-day drop of 15.60% and a cumulative crash of nearly 40% over five trading days, reducing its market cap to HK$22.8 billion. While revenue is strong, losses persist; the company expects 2025 revenue of RMB 401M to 425M (up 65%-75% YoY), with core FastAGI growth exceeding 175%. However, estimated net losses remain as high as RMB 905M to 965M, bringing cumulative losses over the last four years to over RMB 3 billion.
NewTimeSpace News,On March 11, Singapore-listed Seatrium Limited announced the completion of the divestment of Crescent Yard. Together with the disposal of other non-core assets disclosed in previous announcements, this divestment is expected to bring the company annualized cost savings of over S$50 million per year.
NewTimeSpace News,As disclosed in an announcement on the Singapore Exchange on March 11, Continuum Energy stated that its existing shareholder Just Climate and its limited partner will make a $67.5 million follow-on equity investment in the company, with the funds earmarked to support the deployment of the company's wind-solar hybrid power generation and energy storage projects across India.
NewTimeSpace News,Singapore Exchange announced on March 10 that Canacol Energy Ltd. has completed the first subsequent advance under its Debtor-in-Possession (DIP) financing. All precedent conditions set out in the DIP Financing Commitment Letter have been satisfied for this advance, and the relevant financing arrangement has previously obtained approvals from the Canadian and U.S. courts.
NewTimeSpace: CR Construction Group Holdings Limited (01582.HK) announced that its indirectly wholly-owned subsidiary, CR Construction Co., Ltd., has signed a letter of acceptance in respect of the main construction works contract for the development of a logistics centre in Kwai Chung, New Territories, Hong Kong, with a contract value of approximately HK$3.6 billion. The Group will act as the main contractor for the project.
NewTimeSpace: HBM Holdings Limited (02142.HK) announced that the Investigational New Drug (IND) application for HBM7575 (also known as SKB575), a long‑acting bispecific antibody targeting TSLP and an undisclosed target for the treatment of atopic dermatitis, has been approved by the National Medical Products Administration (NMPA) of China.
NewTimeSpace News,On March 9, AJJ MEDTECH HOLDINGS LIMITED, a Singapore-listed enterprise, announced that its wholly-owned subsidiary AJJ Healthcare Management Pte. Ltd. has signed a four-year supply contract for biodegradable medical consumables valued at approximately S$3 million with a network of Singaporean healthcare institutions, effective June 1.
NewTimeSpace News,On 4 March, Singapore-listed Aspial Lifestyle Limited announced a proposal to transfer its listing status from the SGX Catalist to the SGX Mainboard via an official announcement. As its current public float ratio fails to meet the Mainboard’s requirements, the company’s controlling shareholder plans to sell up to 10 million shares to satisfy the public float conditions for the listing transfer.
Innogen Pharmaceutical-B, which once claimed the title of "Oversubscription King" on the HKEX in 2025, has recently faced a sluggish capital market. As of the close on March 4, 2026, its share price stood at HK$22.28, with a cumulative drop of nearly 20% over the past three days—just a step away from its HK$18.68 offer price. The company’s total market value has shrunk by over HK$10 billion from its early post-listing high to approximately HK$10.18 billion. The company's R&D is highly dependent on a single GLP-1 mechanism. The much-anticipated "weight loss indication" is not expected to complete clinical trials until Q4 2026, with approval potentially pushed to 2027.
NewTimeSpace News,On March 4, Singapore-based UNI-ASIA GROUP LIMITED announced the signing of an agreement with Nihon Shipyard Co., Ltd. for the construction of a 40,000 deadweight tonnage (DWT) eco-specification double-hull bulk carrier, with delivery scheduled for the second half of 2028.
